HIT Health In Tech Inc.

  1. Stocks
  2. Technology
  3. NASDAQ: HIT

Price (delayed)

$1.02

Market cap

$66.84M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.02

Enterprise value

$56.64M

?
Relative Growth: Rel. Growth: 32
Relative Strength: Rel. Strength: 18
Relative Valuation: Rel. Valuation: 23
Relative Profitability: Rel. Profitability: 25

Our Mission To change the non-transparent $4.5 trillion(1) healthcare industry with innovation that removes friction and complexities with vertical integration, process simplification, automation, and digitalization. Health in Tech (“HIT”) is ...

Highlights
HIT's equity has surged by 53% year-on-year and by 26% since the previous quarter
Health In Tech's revenue has surged by 52% YoY and by 2.3% QoQ
The company's gross profit rose by 21% YoY but it fell by 4% QoQ
HIT's EPS has dropped by 200% since the previous quarter and by 200% year-on-year
Health In Tech's net income has plunged by 176% YoY and by 163% from the previous quarter
Sector: Technology
Industry: Software - Application
Website: https://healthintech.com
Peers: MSFT ADBE CRM ORCL

Key stats

What are the main financial stats of HIT

HIT stock price

How has the Health In Tech stock price performed over time
Intraday
5.7%
1 week
4.35%
1 month
-32.89%
1 year
61.29%
YTD
-35.85%
QTD
-29.66%

Financial performance

How have Health In Tech's revenue and profit performed over time
Revenue
$34.08M
Gross profit
$20.09M
Operating income
-$1.11M
Net income
-$808,031
Gross margin
58.9%
Net margin
-2.4%
The company's operating income has shrunk by 198% YoY and by 173% QoQ
Health In Tech's net income has plunged by 176% YoY and by 163% from the previous quarter
The operating margin has dropped by 172% since the previous quarter and by 165% year-on-year
Health In Tech's net margin has shrunk by 163% QoQ and by 150% YoY

Price vs fundamentals

How does HIT's price correlate with its fundamentals

Growth

What is Health In Tech's growth rate over time

Valuation

What is Health In Tech stock price valuation
P/E
N/A
P/B
2.83
P/S
1.72
EV/EBIT
N/A
EV/EBITDA
633.09
EV/Sales
1.66
HIT's EPS has dropped by 200% since the previous quarter and by 200% year-on-year
HIT's equity has surged by 53% year-on-year and by 26% since the previous quarter
The stock's price to book (P/B) is 53% less than its last 4 quarters average of 5.7
Health In Tech's revenue has surged by 52% YoY and by 2.3% QoQ
The price to sales (P/S) is 49% lower than the last 4 quarters average of 3.2

Efficiency

How efficient is Health In Tech business performance
HIT's return on sales has dropped by 164% since the previous quarter and by 142% year-on-year
HIT's return on assets has dropped by 158% since the previous quarter and by 145% year-on-year
The company's return on equity has shrunk by 157% QoQ and by 143% YoY
The ROIC has plunged by 154% from the previous quarter and by 142% YoY

Dividends

What is HIT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for HIT.

Financial health

How did Health In Tech financials performed over time
The total assets has increased by 36% year-on-year and by 25% since the previous quarter
The current ratio is up by 35% year-on-year
Health In Tech's debt is 99% lower than its equity
HIT's equity has surged by 53% year-on-year and by 26% since the previous quarter
Health In Tech's debt has decreased by 36% YoY and by 13% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.